Introduction to clinical positron emission tomography.
Positron emission tomography (PET) scanning with [18F] fluorodeoxyglucose (FDG) has developed over 25 years into a valuable clinical tool used mainly for the evaluation of oncology patients. The purpose of this article is to provide an introduction to the basic scientific concepts of FDG-PET imaging as well as to illustrate its clinical utility.
Agress
H
H
Department of Radiology, Hackensack University Medical Center, NJ, USA.
D000230:Adenocarcinoma / Q000000981:diagnostic imaging; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002283:Carcinoma, Bronchogenic / Q000000981:diagnostic imaging; D003110:Colonic Neoplasms / Q000000981:diagnostic imaging; D005260:Female; D019788:Fluorodeoxyglucose F18; D006689:Hodgkin Disease / Q000000981:diagnostic imaging; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging; D008297:Male; D008875:Middle Aged; D019275:Radiopharmaceuticals; D014055:Tomography, Emission-Computed
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18